HEAD PIC.png

Products

Polygon 4.png
Enzymes in the industry

Biofuels

Production of fatty acid methyl esters, decomposition of lignocellulolytic material for bioethanol production.

Enzymes: Lipase, cellulase, xylanase

pexels-jill-burrow-6387879_edited.jpg
Polygon 4.png

Pharmaceuticals

Synthesis of intermediates for production of active pharmaceutical ingredients.

Enzymes: Nitrile hydratase, transaminase, monoamine oxidase, lipase, penicillin acylase

Paper and pulp

Removal of lignin for improved bleaching, improvement in fiber properties.

Enzymes: Lipase, cellulase, xylanase

Detergents

Rectangle 38.png

Conversion of starch to glucose, production of high fructose corn syrup, production of prebiotics, debittering of fruit juice.

Food Processing

Enzymes: Protease, lipase, amylase, cellulase

Stain removal, removal of fats and oils, colour retention.

Enzymes: Trypsin, amylase, glucose isomerase, papain, pectinase

DexTrap

Immobilized dextranase on PepTrap

Dextran is a polysaccharide gum produced by contaminating microbes in the sugar processing pipeline.

This gum poses significant mechanical problems in sugar processing as well as decreasing the overall yield and purity of the final sugar product, resulting in major economic losses.

DexTrap comprises a highly active immobilised dextranase enzyme, capable of breaking down the contaminating dextran gums into simple sugars.

Growth Factors

Growth factors for the cultured meat industry

Cell cultured meat is exploding globally and is expected to be worth more than $21 billion by 2035.

The industry is being held back by the enormous cost of the growth media used to feed the rapidly dividing cells. Alarmingly, over 96% of the cost of growth media is attributed to just three growth factors (IGF, bFGF and TGF-β). Driving down these costs is essential for the cultivated meat industry to reach price parity with plant- and animal-based meats.

 

Immobazyme has developed a modular protein expression system that enables the production of food-grade versions of these growth factors at a fraction of the cost of current offerings.